Position in CSBR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,393,225
-$193,718 QoQ
Shares Held
242,300
+5.5% QoQ
Ownership
1.74%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CSBR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. CSBR ranks #234 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in CSBR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,393,225 | 242,300 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,586,943 | 229,659 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,228,608 | 189,600 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $961,785 | 130,500 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $767,589 | 88,432 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $624,753 | 72,900 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $281,486 | 57,800 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $222,827 | 43,100 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $199,430 | 40,700 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $51,142 | 9,100 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $68,931 | 11,100 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $70,818 | 11,100 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $36,582 | 9,100 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $35,601 | 7,894 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $58,500 | 7,800 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $43,200 | 5,400 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $55,332 | 6,806 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $62,983 | 7,534 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $70,702 | 6,925 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $203,931 | 19,838 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $183,172 | 16,210 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $208,256 | 19,301 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $146,444 | 15,832 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $128,332 | 13,424 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $71,572 | 9,672 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||